Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraseasonal short-time updosing schedule for Alutard SQ in grass pollen allergic rhinoconjunctivitis
2007-000921-23Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Apr 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinoconjunctivitis (ARC) comparing Alutard SQ intraseasonal short-time updosing with Placebo (2 arms). Started Apr 2007; status: completed.
02
Drugs
alutard-sq
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on 2007-000921-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000921-23.